Here are the 424B prospectus supplements from My Size, Inc (MYSZ) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow MYSZ and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MYSZ filings page.
My Size, Inc. (MYSZ) registered for resale up to 4,018,326 shares of common stock issuable upon exercise of warrants held by selling stockholders. My Size receives no proceeds from resales, but may receive proceeds if holders exercise warrants for cash.
The related private placement closed September 16, 2026, generating approximately $2.5 million in gross proceeds before fees and expenses. Pre-funded warrants are immediately exercisable at $0.001 per share and do not expire until exercised in full; Series C and D warrants are immediately exercisable at $1.66 per share, with five-year and 18-month terms, respectively, from the resale registration statement’s effective date. If all Private Placement Warrants and Placement Agent Warrants were exercised for cash in full, proceeds would be approximately $4.57 million; My Size intends to use any net proceeds for general corporate purposes and working capital.
On September 14, 2026, My Size announced an acquisition-led strategy to evaluate potential defense-technology acquisitions, subject to suitable targets, due diligence, definitive agreements, financing and required approvals. Its 2025 audit report states that significant losses, negative operating cash flows and accumulated deficit raise substantial doubt about its ability to continue as a going concern.
My Size, Inc. has registered up to 3,252,404 shares of common stock for resale by Square Gate Capital Master Fund, LLC – Series 5. This includes 3,125,000 ELOC Shares, 33,654 Initial Commitment Shares and up to 93,750 True-Up Commitment Shares tied to future share prices.
These shares support a three-year $10,000,000 equity line facility under an Equity Purchase Agreement that allows, but does not obligate, My Size to sell stock to Square Gate. My Size will not receive proceeds from investors’ resale of these shares, only from any primary sales it elects to make to Square Gate.
The company highlights risks of substantial dilution, potential share price pressure from resales, strict 4.99% ownership and 19.99% exchange caps, and Nasdaq listing risks, including a low Market Value of Listed Securities. Its auditors have previously raised substantial doubt about its ability to continue as a going concern.